Chuanqiang Wu
Key Laboratory Of Cancer Prevention And Therapy, P.R. China
Tianjin, 300060, China
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Journal: International journal of oncology
Published: February 23, 2019
A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma.
Journal: American journal of cancer research
Published: February 17, 2019
TGF-β-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions.
Journal: Cancer letters
Published: June 05, 2018
Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion.
Journal: International journal of oncology
Published: November 30, 2017
[Retracted] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion.
Journal: International journal of oncology
Published: November 30, 2017
[Corrigendum] Role of the EZH2/miR‑200 axis in STAT3‑mediated OSCC invasion.
Journal: International journal of oncology
Published: November 30, 2017
EGFRwt/vIII-PKM2-β-catenin cascade affects proliferation and chemo-sensitivity in head and neck squamous cell carcinoma.
Journal: American journal of cancer research
Published: August 07, 2017
STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 16, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026